23:21 , May 21, 2019 |  BC Extra  |  Company News

May 21 Company Quick Takes: Verily in deal with pharmas; plus Amryt-Aegerion, Prokaryotics

Verily, pharmas partner to develop clinical programs  The Verily Life Sciences LLC of Alphabet Inc. (NASDAQ:GOOG) partnered with Novartis AG (NYSE:NVS; SIX:NOVN), Otsuka Holdings Co. Ltd. (Tokyo:4578), Pfizer Inc. (NYSE:PFE) and Sanofi (Euronext:SAN; NASDAQ:SNY) to...
11:00 , Apr 18, 2019 |  BioCentury  |  Finance

Arranging Arrakis' syndicate

As it raised a $75 million series B round that will help its early research coalesce into a preclinical pipeline, Arrakis sought an investor syndicate that would build its expertise as it seeks to become...
20:03 , Feb 11, 2019 |  BC Extra  |  Company News

Agios' Schenkein joins GV

Less than two weeks after stepping down as CEO of Agios Pharmaceuticals Inc. (NASDAQ:AGIO), David Schenkein has joined GV as general partner. Schenkein, who will remain executive chairman of Agios, will co-lead the firm’s life...
17:52 , Jan 11, 2019 |  BC Week In Review  |  Financial News

Verily raises $1B

Verily Life Sciences LLC (South San Francisco, Calif.) said on Jan. 3 it raised a $1 billion investment round led by new investor Silver Lake. The Alphabet Inc. (NASDAQ:GOOG) unit said the new funds will...
20:21 , Jan 7, 2019 |  BC Extra  |  Politics & Policy

FDA launching new digital health regulatory framework

FDA Monday announced the launch of a new streamlined regulatory framework for digital health devices. The framework will initially be used only for products FDA classifies as software as a medical device (SaMD), which includes...
23:58 , Jan 3, 2019 |  BC Extra  |  Financial News

Verily raises $1B

Verily Life Sciences LLC (South San Francisco, Calif.) said Thursday it raised a $1 billion investment round led by new investor Silver Lake. The Alphabet Inc. (NASDAQ:GOOG) unit said the new funds will be used...
01:15 , Dec 22, 2018 |  BioCentury  |  Product Development

A year of digital progress at Novartis

Novartis AG Chief Digital Officer Bertrand Bodson is capping off his inaugural year with the pharma’s first approval of a digital therapeutic and 10 deals under his belt to integrate new technologies throughout the company....
04:43 , Dec 15, 2018 |  BioCentury  |  Product Development

O’Day’s expansive task at Gilead

A fresh executive team and a track record of building deep portfolios could allow incoming Gilead Sciences Inc. chairman and CEO Daniel O’Day to do what his predecessors couldn’t: make Gilead a leader outside of...
04:44 , Nov 30, 2018 |  BC Week In Review  |  Company News

Merck KGaA, Palantir team up to drive cancer research data collaboration

Merck KGaA (Xetra:MRK) and big data company Palantir Technologies (Palo Alto, Calif.) plan to create a JV under the name Syntropy to help facilitate collaboration among cancer researchers. Syntropy will offer a data integration software...
23:35 , Nov 20, 2018 |  BC Extra  |  Company News

Merck KGaA, Palantir team up to drive cancer research data sharing and integration

Merck KGaA (Xetra:MRK) and big data company Palantir Technologies (Palo Alto, Calif.) plan to create a JV under the name Syntropy to help facilitate collaboration among cancer researchers. Syntropy will offer a data integration software...